Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples ...
pTau217, also called phosphorylated tau at threonine 217, is a specific blood-based biomarker for brain amyloid β pathology. When validated against CSF Aβ42/40 and PET imaging, the biomarker showed ...
Because blood is so easy to sample, scientists like to screen this biofluid when looking for disease associations. Alas, that is not the best approach for neurodegenerative disorders, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results